Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Rajko Kušec

18552

Rajko

Kušec

dr. sc.

Naziv Uloga Akcije
Genetika i funkcija hematopoeze i mikrookoliša Ph- mijeloproliferativnih bolesti voditelj
Genotip-fenotip korelacija u Alportovom sindromu i nefropatiji tankih glomerularnih bazalnim membrana suradnik
Naziv Akcije
Lucijanic, Marko ; Veic, Petra ; Aric, Ivona ; Tupek, Katarina Marija ; Soric, Ena ; Sabljic, Anica ; Vlasac Glasnovic, Josipa ; Stoos-Veic, Tajana ; Krecak, Ivan ; Kusec, Rajko Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time // Annals of hematology, (2023), doi: 10.1007/s00277-023-05305-3
Lucijanic, Marko ; Krecak, Ivan ; Soric, Ena ; Sabljic, Anica ; Galusic, Davor ; Holik, Hrvoje ; Perisa, Vlatka ; Peric, Martina Moric ; Zekanovic, Ivan ; Kusec, Rajko Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis // Biochemia medica, 33 (2023), 2; 020901, 8. doi: 10.11613/bm.2023.020901
Lucijanić, Marko ; Krečak, Ivan ; Sorić, Ena ; Galušić, Davor ; Holik, Hrvoje ; Periša, Vlatka ; Morić Perić, Martina ; Zekanović, Ivan ; Kušec, Rajko Palpable spleen size is differently prognostic in primary and secondary myelofibrosis // Leukemia & lymphoma, 64 (2023), 4; 893-896. doi: 10.1080/10428194.2023.2179360
Lucijanic, Marko ; Jurin, Ivana ; Sedinic Lacko, Martina ; Soric, Ena ; Sabljic, Anica ; Krecak, Ivan ; Mitrovic, Josko ; Marelic, Daniela ; Kremer, Zvonimir ; Hadzibegovic, Irzal et al. Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients // Thrombosis research, 214 (2022), 37-39. doi: 10.1016/j.thromres.2022.04.009
Sabljić, Anica ; Sedinić Lacko, Martina ; Kušec, Rajko ; Pejša, Vlatko ; Lucijanić, Marko No Evident Prognostic Benefit of Statin Use in Diffuse Large B-Cell Lymphoma Patients with Unfavorable Disease Features Treated with R-DA- EPOCH // Pharmacology, 107 (2022), 11-12; 623-627. doi: 10.1159/000526625
Hasselbalch, Hans ; Skov, Vibe ; Kjær, Lasse ; Larsen, Morten Kranker ; Knudsen, Trine A. ; Lucijanić, Marko ; Kušec, Rajko Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives // Cancers, 14 (2022), 22; 5495, 14. doi: 10.3390/cancers14225495
Lucijanić, Marko ; Krečak, Ivan ; Sorić, Ena ; Sabljić, Anica ; Galušić, Davor ; Holik, Hrvoje ; Periša, Vlatka ; Morić Perić, Martina ; Zekanović, Ivan ; Kušec, Rajko Estimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks // Clinical Lymphoma Myeloma & Leukemia. 2022. str. S341-S342 doi: 10.1016/s2152-2650(22)01467-7
Lucijanić, Marko ; Huzjan Korunić, Renata ; Sedinić, Martina ; Kovačević, Stjepan ; Atić, Armin ; Pejša, Vlatko ; Kušec, Rajko Baseline and progressive adipopenia in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features are associated with worse clinical outcomes // Leukemia & lymphoma, 63 (2022), 7; 1556-1565. doi: 10.1080/10428194.2022.2034160
Lucijanić, Marko ; Krečak, Ivan ; Sorić, Ena ; Sabljić, Anica ; Galušić, Davor ; Holik, Hrvoje ; Periša, Vlatka ; Morić Perić, Martina ; Zekanović, Ivan ; Kušec, Rajko Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis // Leukemia research, 119 (2022), 106905, 4. doi: 10.1016/j.leukres.2022.106905
Lucijanić, Marko ; Sorić, Ena ; Sedinić Lacko, Martina ; Sabljić, Anica ; Krečak, Ivan ; Bistrović, Petra ; Jordan, Ana ; Manola, Šime ; Jakšić, Ozren ; Lucijanić, Tomo et al. Gradual increase in red cell distribution width is similarly prognostic for in-hospital mortality in both anemic and non-anemic COVID-19 patients // Journal of medical virology, 94 (2022), 8; 3509-3511. doi: 10.1002/jmv.27785
nije evidentirano
nije evidentirano